Kazunori Iwanaga
Division of Pharmaceutics
Osaka University of Pharmaceutical Sciences
Osaka 569-1094
Japan
Name/email consistency: high
- Effects of furanocoumarins in Kampo extract-based medicines on rat intestinal absorption of CYP3A and P-glycoprotein substrate drugs in vivo. Iwanaga, K., Arimune, K., Miyazaki, M., Shibano, M., Taniguchi, M., Baba, K., Kakemi, M. Arch. Pharm. Res. (2012)
- Application of organogels as oral controlled release formulations of hydrophilic drugs. Iwanaga, K., Kawai, M., Miyazaki, M., Kakemi, M. Int. J. Pharm (2012)
- Characterization of organogel as a novel oral controlled release formulation for lipophilic compounds. Iwanaga, K., Sumizawa, T., Miyazaki, M., Kakemi, M. Int. J. Pharm (2010)
- Furanocoumarin derivatives in Kampo extract medicines inhibit cytochrome P450 3A4 and P-glycoprotein. Iwanaga, K., Hayashi, M., Hamahata, Y., Miyazaki, M., Shibano, M., Taniguchi, M., Baba, K., Kakemi, M. Drug Metab. Dispos. (2010)
- Disposition of lipid-based formulation in the intestinal tract affects the absorption of poorly water-soluble drugs. Iwanaga, K., Kushibiki, T., Miyazaki, M., Kakemi, M. Biol. Pharm. Bull. (2006)
- Usefulness of microspheres composed of gelatin with various cross-linking density. Iwanaga, K., Yabuta, T., Kakemi, M., Morimoto, K., Tabata, Y., Ikada, Y. J. Microencapsul (2003)









